Compare places
Two or three clusters, read side by side across sectors, research, companies, capital, infrastructure, government designations and UKIZ relevance. There is no score and no ranking: British clusters are different from one another, not better or worse than one another.
Choose up to three clusters
- London
- Cambridge
- Oxford
- Manchester
- Birmingham & the West Midlands
- Bristol & Bath
- Sheffield & Rotherham
- Leeds & West Yorkshire
- Liverpool City Region
- Newcastle & the North East
- Teesside & the Humber
- Edinburgh
- Glasgow & the Central Belt
- Belfast
- Cardiff & South Wales
- Southampton & Portsmouth
- Cornwall & Plymouth
- Nottingham & Derby
- Norwich & the East
Side by side
| Dimension | Leeds & West YorkshireYorkshire and the Humber | Liverpool City RegionNorth West | LondonGreater London |
|---|---|---|---|
| Sectors | Life Sciences, Digital Technologies, Financial Technology Supporting: Artificial Intelligence, Advanced Manufacturing, Creative Industries | Life Sciences, Engineering Biology, Advanced Materials Supporting: Digital Technologies, Clean Energy, Creative Industries | Financial Technology, Artificial Intelligence, Creative Industries, Digital Technologies Supporting: Life Sciences, Quantum Technologies, Engineering Biology, Defence & Security |
| Research |
|
|
|
| Companies |
| Not recorded on the map. | Not recorded on the map. |
| Infrastructure | Not recorded on the map. Health data infrastructure, teaching hospitals and university research facilities. | Not recorded on the map. University research institutes, automated chemistry facilities and port and logistics assets. |
University laboratories, teaching hospitals, data centre and compute capacity, and the densest transport network in the country. |
| Capital | Financial services depth locally, but early-stage health technology capital remains limited. | A modest local investor base; public and charitable research funding dominate. |
Venture, growth and public market capital at a scale unmatched elsewhere in Europe, plus corporate venture arms and international investors with UK offices. |
| Government programmes | No place-based designation recorded. |
| No place-based designation recorded. |
| What exists | National health data organisations, medical technology, a large financial and professional services base and a research university with data and materials strength. | Infection and tropical medicine research of international standing, materials chemistry and automated discovery, a large port and a Freeport designation. | Four research-intensive universities, the deepest venture and growth capital pool in Europe, financial regulators, the largest concentration of applied AI companies in the UK and a global-scale creative production economy — all within one travel-to-work area. |
| What's missing · UKIZ interpretation | A clear route for companies to work with health data at scale, and clinical adoption pathways that move faster than pilot projects. | Translation capacity: strong discovery science with limited local scale-up manufacturing and limited early-stage capital to hold companies in the city region. | Circulation. Capital, talent and corporate demand concentrate in London rather than flowing outward, so capability elsewhere in Britain competes for attention with opportunities on the investor's doorstep. Cost also pushes production and scale-up activity out without a route back in. |
| What could connect · UKIZ interpretation | Leeds health data capability connected to Manchester clinical research and to medical technology manufacturing, giving companies discovery, evidence and production in one region. | Infection and biologics research connected to North West and Teesside biomanufacturing capacity, with the port used for export rather than only import. | London as the demand and capital node of a national network: investors, corporate buyers and regulators deliberately connected to complementary manufacturing, materials and energy capability in the North, Midlands, Scotland and Wales. |
| UKIZ relevance | Health data at population scale is a national asset. The proposed Manchester mission and Leeds capability are complementary rather than competing. | Discovery and manufacture sit unusually close together here. The proposed Manchester mission treats the North West as one health and biomanufacturing geography. | London's problem is not capability, it is direction of travel: capital and talent gravitate here rather than circulating. The proposed London zone focuses on using that density to fund and buy from capability elsewhere in Britain. |
| Last verified | 15 August 2026 | 15 August 2026 | 15 August 2026 |
Proposed by UKIZ · independent · not a government designation